Top

Huisarts en wetenschap

Gepubliceerd in:

01-10-2012 | Klinische Les

Mild Cognitive Impairment

Auteurs: J. H. Verwoerd, dr. F. U. S. Mattace-Raso

Gepubliceerd in: Huisarts en wetenschap | Uitgave 10/2012

Samenvatting

Verwoerd JH, Mattace-Raso FUS. Mild Cognitive Impairment. Huisarts Wet 2012;55(10):464-7.

Mild Cognitive Impairment (MCI) is een heterogeen ziektebeeld dat geriaters en neurologen de laatste jaren geregeld diagnosticeren en waarnaar men veel onderzoek doet. MCI betreft een lichte cognitieve achteruitgang die erger is dan men op basis van leeftijd mag verwachten, maar die niet aan de diagnose dementie voldoet. Men stelt de diagnose op basis van anamnese en heteroanamnese, bij voorkeur aangevuld met een objectieve test om de cognitieve status in kaart te brengen. MCI is een belangrijke risicofactor voor het ontwikkelen van dementie; jaarlijks krijgt 5-15% van de patiënten met MCI dementie. Er zijn geen therapeutische opties voor MCI. Wel is het belangrijk eventuele somatische factoren te behandelen. Vooralsnog lijkt het vooral voor de huisarts belangrijk om de achtergrond van een gediagnosticeerde MCI of aangegeven lichte cognitieve problemen te kennen, en patiënten en hun naasten te begeleiden. Het stellen van de diagnose MCI door de huisarts zelf lijkt hierbij geen meerwaarde te hebben.

vorige artikel Ovarium- en tubacarcinoom, nieuwe ontwikkelingen

volgende artikel Abstract

Petersen RC. Clinical practice. Mild cognitive impairment. NEJM 2011;364:2227–34.PubMedCrossRef

Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–8.PubMedCrossRef

Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133–42.PubMedCrossRef

Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–6.PubMedCrossRef

Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94.PubMedCrossRef

Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397–405.PubMedCrossRef

Werner P, Korczyn AD. Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging 2008;3:413–20.PubMed

Gauthier S, Touchon J. Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 2005;62:1164–6; discussion 1167.

Whitehouse P, Brodaty H. Mild cognitive impairment. Lancet 2006;367:1979.PubMedCrossRef

10.

Whitehouse PJ. Mild cognitive impairment - a confused concept? Nat Clin Pract Neurol 2007;3:62–3.PubMedCrossRef

11.

Maggini M, Vanacore N, Raschetti R. Cholinesterase inhibitors: drugs look ing for a disease? PLoS Med 2006;3:e140.PubMedCrossRef

12.

Ganguli M, Blacker D, Blazer DG, Grant I, Jeste DV, Paulsen JS, et al. Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry 2011;19:205–10.PubMedCrossRef

13.

Ward A, Arrighi HM, Michels S, Cedarbaum JM. Mild cognitive impairment: Disparity of incidence and prevalence estimates. Alzheimers Dement 2012;8:14–21.PubMedCrossRef

14.

Moll van Charante E, Perry M, Vernooij-Dassen MJFJ, Boswijk DFR, Stoffels J, Achthoven L, et al. NHG-Standaard Dementie (derde herziening). Huisarts Wet 2012;55:306–17.

15.

Mitchell AJ. A meta-analysis of the accuracy of the Mini-Mental State Exam ination in the detection of dementia and mild cognitive impairment. J Psychiatr Res 2009;43:411–31.PubMedCrossRef

16.

Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–9.PubMedCrossRef

17.

Tang-Wai DF, Knopman DS, Geda YE, Edland SD, Smith GE, Ivnik RJ, et al. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. Arch Neurol 2003;60:1777–81.PubMedCrossRef

18.

Freitas S, Simões MR, Alves L, Santana I. Montreal Cognitive Assessment: Validation Study for Mild Cognitive Impairment and Alzheimer Disease. Alzheimer Dis Assoc Disord 2011 Dec 20 [Epub ahead of print].

19.

Muangpaisan W, Petcharat C, Srinonprasert V. Prevalence of potentially reversible conditions in dementia and mild cognitive impairment in a ger iatric clinic. Geriatr Gerontol Int 2012;12:59–64.PubMedCrossRef

20.

Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;119:252–65.PubMedCrossRef

21.

Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Int Med 2008;148:427–34.PubMed

22.

Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol 2009;66:1151–7.PubMedCrossRef

23.

Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008;63:494–506.PubMedCrossRef

24.

Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 2008;56:1424–33.PubMedCrossRef

25.

Mitchell AJ, Shiri-Feshki M. Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis. J Neurol Neurosurg Psychiatry 2008;79:1386–91.PubMedCrossRef

26.

Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry 2007;64:1443–50.PubMedCrossRef

27.

Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2007;68:1588–95.PubMedCrossRef

28.

Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006;67:1201–7.PubMedCrossRef

29.

Kryscio RJ, Schmitt FA, Salazar JC, Mendiondo MS, Markesbery WR. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology 2006;66:828–32.PubMedCrossRef

30.

Tyas SL, Salazar JC, Snowdon DA, Desrosiers MF, Riley KP, Mendiondo MS, et al. Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol 2007;165:1231–8.PubMedCrossRef

31.

Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, Farchi G, et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology 2007;68:1909–16.PubMedCrossRef

32.

Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011;76:1485–91.PubMedCrossRef

33.

Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008;CD004514.

34.

Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2006;CD001747.

35.

Isaac MG, Quinn R, Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2008;CD002854.

36.

Birks J, Flicker L. Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 2006;CD006104.

37.

Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F. Cognitionbased interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 2011;CD006220.

38.

Joosten-Weyn Banningh LW, Prins JB, Vernooij-Dassen MJ, Wijnen HH, Olde Rikkert MG, Kessels RP. Group therapy for patients with mild cognitive impairment and their significant others: results of a waiting-list controlled trial. Gerontology 2011;57:444–54.PubMed

39.

Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc 2011;86:876–84.PubMedCrossRef

40.

Lautenschlager NT, Cox KL, Flicker L, Foster JK, Van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008;300:1027–37.PubMedCrossRef

41.

Jansen APD, Van Hout HPJ, Nijpels G, Rijmen F, Dröes RM, Pot AM, et al. Casemanagement bij beginnende dementie. Huisarts Wet 2011;55:58–63.CrossRef

42.

Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, et al. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ 2008;178:1273–85.PubMedCrossRef

43.

Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006;332:455–9.

44.

Iliffe S, Manthorpe J, Eden A. Sooner or later? Issues in the early diagnosis of dementia in general practice: a qualitative study. Fam Pract 2003;20:376–81.PubMedCrossRef

45.

Joosten-Weyn Banningh L, Vernooij-Dassen M, Rikkert MO, Teunisse JP. Mild cognitive impairment: coping with an uncertain label. Int J Geriatr Psychiatry 2008;23:148–54.PubMedCrossRef

Titel: Mild Cognitive Impairment
Auteurs: J. H. Verwoerd
dr. F. U. S. Mattace-Raso
Publicatiedatum: 01-10-2012
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Huisarts en wetenschap / Uitgave 10/2012
Print ISSN: 0018-7070
Elektronisch ISSN: 1876-5912
DOI: https://doi.org/10.1007/s12445-012-0228-y

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 10/2012

Vitamine-B12-bepaling bij metforminegebruik

PATIËNTVEILIGHEID

Aspirine voorkomt recidief trombose

Palliatieve sedatie: hoe diep?

Een potentieel fatale complicatie van een tonsillitis

Kwaliteit van leven in de laatste fase